Enzo Biochem Inc/ US2941001024 /
| 2024-04-23 10:10:00 PM | Chg. 0.00 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.09USD | 0.00% | 76,123 Turnover: 75,509.90 |
1.00Bid Size: 100 | 1.31Ask Size: 100 | 55.84 mill.USD | - | 2.66 |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 7.9010 | 7.6360 | 14.2540 | 14.4820 | 16.5850 | ||||||
| Intangible Assets | 2.8950 | 1.8860 | 1.0320 | .5380 | .2440 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 18.5810 | 18.4600 | 25.1870 | 43.7730 | 43.1090 | ||||||
| Inventories | 7.0470 | 7.2780 | 7.8420 | 7.7840 | 12.6520 | ||||||
| Accounts Receivable | 15.1800 | 13.1470 | 10.7380 | 9.1410 | 10.1980 | ||||||
| Cash and Cash Equivalents | 64.1670 | 60.0410 | 60.1460 | 47.8650 | 13.5240 | ||||||
| Current Assets | 89.0840 | 83.2000 | 81.4530 | 68.7650 | 70.5820 | ||||||
| Total Assets | 107.6650 | 101.6600 | 106.6400 | 112.5380 | 113.6910 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10.3500 | 9.5160 | 7.2560 | 8.5030 | 8.1230 | ||||||
| Long-term debt | - | - | 4.1790 | 4.4850 | 4.4710 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 6.7000 | 10.1000 | 8.4000 | 12.8000 | - | ||||||
| Liabilities | 18.7930 | 20.5390 | 20.6120 | 54.1570 | 45.1050 | ||||||
| Share Capital | - | .4720 | .4760 | .4790 | .4850 | ||||||
| Total Equity | 88.8720 | 81.1210 | 86.0280 | 58.3810 | 68.5860 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 107.6650 | 101.6600 | 106.6400 | 112.5380 | 113.6910 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 107.8040 | 104.7130 | 81.1700 | 76.0210 | 117.7310 | ||||||
| Depreciation (total) | 3.5980 | 3.1300 | 3.0360 | 2.7800 | 2.6530 | ||||||
| Operating Result | -3.0660 | -12.1640 | 1.7330 | -30.3670 | .6920 | ||||||
| Interest Income | .3840 | .8530 | 1.0560 | .4540 | .0080 | ||||||
| Income Before Taxes | -2.4220 | -11.4180 | 2.4890 | -28.5200 | 7.8750 | ||||||
| Income Taxes | .0820 | -1.0970 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -2.5040 | -10.3210 | 2.4890 | -28.5200 | 7.8750 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -.2050 | -2.7350 | 4.8060 | -17.1790 | .3870 | ||||||
| Cash Flow from Investing Activities | -1.7490 | -1.9440 | -8.1260 | -2.1700 | -34.4970 | ||||||
| Cash Flow from Financing | -1.6690 | .5590 | 4.1930 | 7.0010 | -.2420 | ||||||
| Decrease / Increase in Cash | -3.6100 | -4.1260 | .8550 | -12.2810 | -34.3410 | ||||||
| Employees | 472 | 460 | 500 | 448 | - | ||||||
